Advances Against Aspergillosis II Clinical Science, Volum 1273

"The papers included in two volumes of Annals of the New York Academy of Sciences provide a cross-section of the information presented at the 5th 'Advances Against Aspergillosis'"--Page viii.

About the author

Karl V Clemons, Stanford University, Stanford, California. Malcolm Richardson, University of Manchester, Manchester, United Kingdom. David S Perlin, UMDNJ-New Jersey Medical School, Newark, New Jersey.

Summary

Aspergillosis, the leading fungal cause of mortality in immunocompromised patients, presents a serious worldwide challenge particularly in the face of increasing antifungal resistance.

Product details

• Assisted by: Karl V. Clemons (Editor), David S. Perlin (Editor), Malcolm D. Richardson (Editor), Richardson Malcolm D. (Editor), Malcolm D. (University of Helsinki Richardson (Editor), Malcolm D Richardson (Editor), Karl V Clemons (Editor), David S Perlin (Editor), Karl V. (Stanford University; Santa Clara Valley Medical Centre) Clemons (Editor), Clemons Karl V. (Editor), Perlin David S. (Editor)
• Authors: Karl V. Clemons, David S. Perlin, Malcolm D. Richardson, Karl V. Richardson Clemons, CLEMONS KARL V RICHARDSON MALCO, K Clemons
• Publisher: New york academy of sciences
• Content: Book
• Product form: Paperback / Softback
• Publication date: 22.02.2013
• Subject: Natural sciences, medicine, IT, technology > Biology > General, dictionaries
• EAN: 9781573319157
• ISBN: 978-1-57331-915-7
• Pages: 84
• Series: Annals of the New York Academy of Sciences; Annals of the New York Academy; Annals of the New York Academy of Sciences; Annals of the New York Academy
• Subjects: Short, Microbiology (non-medical), treatment, SCIENCE / Life Sciences / Ecology, Children, Clinical, SCIENCE / Life Sciences / Microbiology, Invasive, Application, agents, Risk, Diagnostic, Ecological science, the Biosphere, Topics, use, Stratification, Markers, aspergillosis, Findings, contain, encapsulating, immunocompromised patients